Nitto Denko

Bend Labs, Inc. specializes in the development and manufacturing of integrated motion measurement systems aimed at remote healthcare applications. The company has created a wearable soft sensor platform designed to measure human motion, featuring products like the Smart Knee, which includes integrated sensors and low energy Bluetooth technology to track knee usage and complex movements in real time. In addition to its primary offerings, Bend Labs provides bend, stretch, and pressure sensors, complemented by an Android app and API that facilitate connectivity with its platform. Founded in 2013 and headquartered in Salt Lake City, Utah, Bend Labs aims to enable sensor integration by collaborating with companies from the prototyping phase to large-scale commercial manufacturing and licensing. The company's innovative technology is expected to play a significant role in the future of smart garments, virtual reality gloves, and remote medical devices.

C3Nano is a company that specializes in developing transparent conductive inks and films, serving as direct replacements for indium tin oxide (ITO). Founded in 2010 and headquartered in Hayward, California, C3Nano is recognized as a leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire solution-based inks, primarily for the touch sensor and display industry. Its products are designed to enhance the touchscreen and digital display experience by providing superior scratch resistance, durability, and optical clarity. Additionally, these inks and films are compatible with a wide range of substrates and processing techniques, enabling clients to address the growing demand for flexible touch sensor applications. The company has established a strong manufacturing presence in Korea and has raised significant funding to advance its ink formulations and production capabilities.

Algotochip specializes in the design of digital chips, specifically Systems on a Chip (SOCs). The company streamlines the design process by significantly reducing both time and costs associated with chip development. Their innovative technology enables the partitioning of customer C-code into optimized modules, which then generate all necessary hardware and corresponding software components for a complete application solution. By transforming behavioral algorithms into architecture-specific code, and subsequently into Register Transfer Level (RTL) and GDS-II formats, Algotochip effectively turns complex algorithms into functional chips, thus enhancing efficiency in digital chip design.

Altea Therapeutics Corporation develops and commercializes transdermal drug delivery systems. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The company also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention products; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. Altea Therapeutics Corporation was formerly known as Altea Development Corporation. The company was founded in 1998 and is based in Atlanta, Georgia. As of May 9, 2012, Altea Therapeutics Corporation operates as a subsidiary of Nitto Denko Corp.

Avecia is a prominent private biotechnology company that specializes in the development and manufacture of innovative biotechnology-based medicines through its OligoMedicines division. The company has a strong history of technological innovation and collaborates closely with biotechnology and pharmaceutical clients. Avecia's focus is on facilitating rapid advancement for these clients as they navigate the clinical development process, ensuring that their products progress efficiently from conception to clinical trials.